CHARLES SCHWAB INVESTMENT MANAGEMENT INC - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 67 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$167,111
+81.6%
11,1780.0%0.00%
Q3 2022$92,000
-18.6%
11,178
-34.9%
0.00%
Q2 2022$113,000
+16.5%
17,1800.0%0.00%
Q1 2022$97,000
+19.8%
17,1800.0%0.00%
Q4 2021$81,000
-24.3%
17,1800.0%0.00%
Q3 2021$107,000
-73.6%
17,180
-68.9%
0.00%
Q1 2021$405,000
+21.3%
55,282
-4.5%
0.00%
Q4 2020$334,000
+16.8%
57,864
+20.2%
0.00%
Q3 2020$286,000
+72.3%
48,145
+49.5%
0.00%
Q2 2020$166,00032,2090.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,952,958$22,809,0000.60%
SECTORAL ASSET MANAGEMENT INC 1,151,175$6,642,0000.47%
X-Square Capital, LLC 75,952$438,0000.24%
SABBY MANAGEMENT, LLC 68,092$393,0000.08%
WealthTrust Axiom LLC 22,347$128,0000.05%
Opaleye Management Inc. 58,800$339,0000.04%
Trexquant Investment LP 64,838$374,0000.04%
PDT Partners, LLC 60,117$347,0000.02%
PERSONAL CFO SOLUTIONS, LLC 13,000$75,0000.02%
CVI Holdings, LLC 13,171$76,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders